Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.

Barbora WeinbergerováJiri MayerTomas KabutStepan HrabovskyJirina ProchazkovaZdenek KralVladimir HeroutRita PacasovaLenka Zdrazilova-DubskaPetr HusaPetr BednarDaniel RuzekMartina Lengerova

Published in: Hematological oncology (2021)

Keyphrases

end stage renal disease
ejection fraction
coronavirus disease
sars cov
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors